In its October 2024 meeting, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) gave the green light for Korjuny (catumaxomab, Lindis Biotech GmbH) to be used ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback